Detalhe da pesquisa
1.
Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.
Scand J Gastroenterol
; 53(10-11): 1347-1353, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30394152
2.
Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden.
Infect Dis (Lond)
; 47(8): 555-62, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25851241
3.
Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on trace elements, inflammation and viral clearance in the myocardium during coxsackievirus B3 infection in mice.
Sci Total Environ
; 284(1-3): 135-47, 2002 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-11846158
4.
Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a.
Antiviral Res
; 99(1): 12-7, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23648709
5.
Bartonella spp. seroprevalence in healthy Swedish blood donors.
Scand J Infect Dis
; 37(10): 723-30, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16191889